We investigated the expression of HIF-1 target genes VEGF and ET-1, well recognized to be involved in cancer progression, by exposing HepG2 tumor cells to hypoxia-reoxygenation cycles mimicking those of OSA [39]. This evidence concerns the gene HIF1A and neoplasm.